{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-055089","form_type":"8-K","ticker":"DTIL","cik":"0001357874","company_name":"PRECISION BIOSCIENCES INC","filed_at":"2024-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.077271+00:00","generated_at":"2026-06-02T09:07:54.698024+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Precision BioSciences sells 25,000 shares at $12 to management in private placement","bullets":["Gross proceeds ~$300k from sale of 25,000 shares at $12.00/share (13.5% premium to prior day close).","CEO Michael Amoroso and CFO Alex Kelly each purchase 8,334 shares ($100k); GC and CRO purchase 833 shares each.","Net proceeds to be used to fund ongoing research and development initiatives; close expected May 8, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-055089","json":"https://secwatch.observer/filing/0000950170-24-055089.json","markdown":"https://secwatch.observer/filing/0000950170-24-055089.md","text":"https://secwatch.observer/filing/0000950170-24-055089.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024055089/0000950170-24-055089-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024055089/dtil-20240508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T09:07:54.698024+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}